It has been reported that CCR3 expression was increased under rheumatoid arthritis conditions, and it mediated eotaxin-1 induced matrix metalloproteinase (MMP)-9 upregulation in fibroblast-like synoviocyte which may further result in articular damage (Liu et al., 2017). Here, CCR3 is linked to rheumatoid arthritis.